U.S. Capital Wealth Advisors LLC Raises Position in HCA Healthcare, Inc. (NYSE:HCA)

U.S. Capital Wealth Advisors LLC boosted its stake in HCA Healthcare, Inc. (NYSE:HCA) by 11.5% in the 4th quarter, Holdings Channel reports. The firm owned 2,951 shares of the company’s stock after buying an additional 305 shares during the quarter. U.S. Capital Wealth Advisors LLC’s holdings in HCA Healthcare were worth $886,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the stock. Terra Nova Asset Management LLC lifted its holdings in HCA Healthcare by 0.3% in the third quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock worth $3,297,000 after acquiring an additional 26 shares during the last quarter. Waldron Private Wealth LLC grew its position in HCA Healthcare by 1.8% in the third quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock worth $683,000 after buying an additional 29 shares during the last quarter. Brookstone Capital Management grew its position in HCA Healthcare by 0.7% during the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock worth $1,652,000 after purchasing an additional 30 shares in the last quarter. UMB Bank n.a. grew its position in HCA Healthcare by 2.4% during the 3rd quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock worth $529,000 after purchasing an additional 30 shares in the last quarter. Finally, Integrated Advisors Network LLC boosted its stake in shares of HCA Healthcare by 0.6% during the 3rd quarter. Integrated Advisors Network LLC now owns 5,132 shares of the company’s stock valued at $2,086,000 after buying an additional 31 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $335.31 on Wednesday. The stock has a market cap of $84.93 billion, a P/E ratio of 15.26, a P/E/G ratio of 1.13 and a beta of 1.64. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The company has a fifty day moving average price of $313.52 and a two-hundred day moving average price of $353.59. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the firm posted $5.90 earnings per share. As a group, equities analysts predict that HCA Healthcare, Inc. will post 24.89 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.86%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.02%.

Insider Buying and Selling

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. This trade represents a 29.76 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares in the company, valued at $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.70% of the stock is owned by insiders.

Analyst Ratings Changes

HCA has been the subject of several analyst reports. Bank of America reduced their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research note on Monday, January 27th. StockNews.com lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Cantor Fitzgerald reiterated an “overweight” rating and set a $405.00 target price on shares of HCA Healthcare in a research report on Monday, January 27th. Finally, TD Cowen cut their price objective on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a report on Monday, October 28th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.